RSS0343 tablets

DRUG2 trials

Sponsors

Reistone Biopharma Company Limited

Conditions

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis

Phase 1

A Clinical Study of RSS0343 in Healthy Subjects

CompletedNCT07289464

Reistone Biopharma Company LimitedNon-cystic Fibrosis Bronchiectasis

Start: 2026-01-08End: 2026-08-10Updated: 2026-08-17

Phase 2

A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease

RecruitingNCT07349524

Reistone Biopharma Company LimitedChronic Obstructive Pulmonary Disease

Start: 2026-03-10End: 2028-04-01Target: 300Updated: 2026-06-05